BioSpace News Archive

Policy

Cepheid Receives FDA Clearance for Xpert® Xpress GBS

Cepheid announced that it has received clearance from the U.S. Food and Drug Administration for Xpert® Xpress GBS, a dual-target molecular diagnostic test for the qualitative intrapartum detection of Group B Streptococcus.

March 11, 2024
·
3 min read
BioForest

Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO

At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows.

March 11, 2024
·
6 min read
Biotech Beach

Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock

Evolus, Inc. announced the pricing of its underwritten offering of 3,554,000 shares of its common stock at a underwritten offering price of $14.07 per share, which is equal to the closing price on Friday, March 8, 2024, before underwriting discounts and commissions.

March 11, 2024
·
4 min read
Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference

Can-Fite BioPharma Ltd. announced its VP of Business Development, Dr. Sari Fishman, will present data from the pancreatic and liver cancer programs during numerous partnering meetings at the BIO-Europe Spring 2024 in Barcelona, Spain, on Mar 18-27, 2024.

March 11, 2024
·
5 min read
Business

Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights

Legend Biotech Corporation, a global leader in cell therapy, reported its fourth quarter and full year 2023 unaudited financial results and key corporate highlights.

March 11, 2024
·
16 min read
Deals

Elevance Health Announces Closing of Paragon Healthcare Acquisition

Elevance Health announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.

March 11, 2024
·
6 min read
Pharm Country

Actinium Pharmaceuticals Launches Actinium-225 Focused Strategic Initiative to Leverage Proprietary Cyclotron Based Manufacturing Technology to Address Growing Market Demand

Actinium Pharmaceuticals, Inc. announced that it has launched a strategic initiative focused on the manufacture of the highly sought after medical isotope Actinium-225 leveraging its propriety cyclotron-based method.

March 11, 2024
·
6 min read
Biotech Bay

Reviva to Present at the UBS Virtual CNS Day

Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a Fireside Chat at the UBS Virtual CNS Day, taking place virtually March 18, 2024.

March 11, 2024
·
1 min read
Business

Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase of Growth

Hyku Biosciences, Inc. today announced the appointment of Kleem Chaudhary, Ph.D. as President and Chief Executive Officer.

March 11, 2024
·
3 min read
BioCapital

Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR

Edwards Lifesciences announced at Cardiovascular Research Technologies 2024 the compelling results from two large, real-world studies based on TVT Registry data that demonstrated continued excellent outcomes for patients treated with the Edwards SAPIEN valve platform.

March 11, 2024
·
5 min read